Santen Pharmaceutical Investor

Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.

Last Funding Type: Series D
Funding Status: M&A
Headquarters: United States
Founded Date: 1890-01-01
Last Funding Date: 2009-09-26
Total Funding: 59000000 EUR
Employee Number: 1001-5000
Number Of Exists: 3
Investors Number: 8
Industry: Biotechnology, Health Care, Manufacturing, Science and Engineering